Drug Markets/Methocarbamol

Methocarbamol

31 NDCs across 11 manufacturers|31 Generic,0 Brand

Methocarbamol is used to treat muscle cramp, muscle rigidity, myositis, pain, spasm and tetanus, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $36 million on Methocarbamol across 3.2 million claims for 1.3 million beneficiaries.

Methocarbamol is available as 31 NDCs from 11 manufacturers (31 generic, 0 brand), with NADAC prices from $0.04 to $8.35 per EAthe most expensive product costs about 210× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

31

31G / 0B

Manufacturers

11

competing in market

Price Spread

$0.04 – $8.35

per EA

7d Activity

14143 flat

avg -0.5% WoW · of 31 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

31 NDCs total, 31 shown

Drug Price 7d Change
TANLOR 1,000 MG TABLET
$8.3480
per EA
METHOCARBAMOL 1,000 MG TABLET
$8.3480
per EA
METHOCARBAMOL 1,000 MG TABLET
$8.3480
per EA
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 750 MG TABLET
$0.0424
per EA
-1.26%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%
METHOCARBAMOL 500 MG TABLET
$0.0397
per EA
+0.30%

Frequently Asked Questions

What is Methocarbamol used to treat?

Methocarbamol is used to treat muscle cramp, muscle rigidity, myositis, pain, spasm and tetanus, per the National Library of Medicine's MED-RT classification.

When did Methocarbamol become available as a generic?

FDA approved the first generic Methocarbamol (ANDA) on Jan 1, 1982. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Methocarbamol?

In 2024, Medicare Part D spent $36 million on Methocarbamol across 3.2 million claims for 1.3 million beneficiaries.

How many Methocarbamol products are on the market?

The Methocarbamol drug market contains 31 NDCs from 11 manufacturers — 31 generic and 0 brand products.

What is the price range for Methocarbamol?

NADAC reference prices for Methocarbamol range from $0.0397 to $8.3480 per EA — the most expensive product costs about 210× the cheapest.

Which manufacturers make Methocarbamol?

11 manufacturers list Methocarbamol in NADAC. Ranked by number of NDCs, the largest are Oxford Pharmaceuticals, LLC (6), Camber Pharmaceuticals Inc. (4), Solco Healthcare US LLC (4), Aurobindo Pharma Limited (4), Unichem Pharmaceuticals (USA) Inc. (4).

How has the price of Methocarbamol changed recently?

Over the past 7 days, 14 Methocarbamol NDCs rose and 14 fell, with a market-wide average change of -0.5%.